is it possible, page-2

There is no question that McQuillan owns the Rolodex that Calzada needs.

At this point in time he is just what's needed on CZD's board. In PolyNovo we have a fully mature technology lacking only commercialization. We need deals with up-fronts and royalties, and this guy can certainly help make those deals happen.

McQuillan must have a virtually complete knowledge of the VAC treatment marketplace as well as for burn and wound treatment.

Right below burn and would management has to be the resorbable stent business, where we went cold at the hands of Medtronics. There has got to be a medical device company out there somewhere who might want to develop what would be the transformative resorbable stent.

Hopefully, McQuillan can help on this front as well.